Learn more about how we're enabling our partners to deliver conversational care.

May 17th, 2018

LifeLink partners with CareThrough to provide high-touch, personalized patient navigation services

“Pairing mobile technology with care navigators helps providers achieve value-based care goals in this new era of the digitally-connected consumer. Our partnership with LifeLink ensures providers can jump the curve to high quality patient engagement and outcomes at scale.” said Dr. Michael Murphy, CEO of HealthChannels.

March 8th, 2018

LifeLink selected by leading cancer centers for major BRCA genetic study

“The BFOR trial seeks to establish a better care management model that enables individuals with heightened risk to gain the genetic insights to take charge of their health.” said Yuri A. Fesko, MD, Medical Director, Oncology, Quest Diagnostics.

March 8th, 2018

23AndMe at-home cancer test: Should I take it? A cancer doc weighs in.

“Genetics needs to be more available to more people. That is clear to all of us. It’s just a matter of people understanding what they’re signing up for and making sure there’s not a misunderstanding or people are not being misled into thinking they don’t have any risk.” — Huma Rana, clinical director for cancer genetics and prevention at the Dana-Farber Cancer Institute, Massachusetts.

March 7th, 2018

You Can Now Order an At-Home Genetic Test for Breast Cancer. But Should You?

“This is not recreational genomics.” — Dr. Kenneth Offit, MD, MPH, Memorial Sloan Kettering Cancer Center, New York City

March 7th, 2018

23andMe Kits Now FDA-Approved as a Genetic Test for Breast Cancer — But Is it Truly Accurate?

“The Food and Drug Administration (FDA) approved the first at-home genetic test for breast cancer genes, opening the door to the next stage in personalized DIY medicine. But how reliable — and how useful — are the results going to be?”